Conducting clinical and health economic outcome studies in an ambulatory setting

Journal of Ambulatory Care Management

Volumn 20, Issue 4, 1997, Pages 10-16

  Ortmeier, Brian G ^a  

^a SANOFI   (France)

Author keywords

Ambulatory care; Disease state management; Health economics; Health outcomes; Managed care; Pharmacoeconomics

Indexed keywords

AMBULATORY CARE; CLINICAL RESEARCH; HEALTH CARE COST; HEALTH ECONOMICS; MANAGED CARE; MEASUREMENT; MODEL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

EID: 0030666218     PISSN: 01489917     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004479-199710000-00003     Document Type: Review

References (14)

1. Baker, A.M., Arnold, R.J., & Kaniecki, D.J. (1995). Considerations in measuring resource use in clinical trials. Drug Information Journal, 29, 1,421-1,428.
2. Blackwell, S.A., Szeinbach, S.L., & Barnes, J.H. (1996, December). A systems-based disease management model: Achieving optimal health care outcomes. Medical Interface, 9, 82-85.
3. Drummond, M.F., & Stoddart, G.L. (1984). Economic analysis and clinical trials. Controlled Clinical Trials, 5, 115-129.
4. Dubois, R. (1996). Reducing costs: The case for disease management. Clinical Performance and Quality Health Care, 4, 226-227.
5. Health Care Financing Administration, Office of the Actuary, 1997.
6. Hitchens, K. (1995). Disease management: The new buzzword. Hospital Pharmacist Report, 9(6), 34-43.
7. Horn, S.D. (1997). Tools and techniques in disease management. Disease Management and Health Outcomes, 1(1), 17-25.
8. Interstudy (1996). Study finds far more programs developed than implemented: Patient volume, cost drive HMOs' DM decisions. Disease Management News, 2, 1, 5, 10.
9. Kozma, C.M. Reeder, C.E., & Schulz, R.M. (1993). Economic, clinical and humanistic outcomes: A planning model for pharmacoeconomic research. Clinical Therapeutics, 15(6), 1,121-1,132.
10. Last, J.M. (1988). A dictionary of epidemiology (2nd ed.). London: Oxford University Press.
11. McGhan, W.F., & Briesacher, B.A. (1994). Implementing pharmacoeconomic outcomes management. Pharmacoeconomics, 6(5), 412-416.
12. Disease Management Congress. (1996). New roles seen for physician, pharmacist, formulary in disease management. Formulary, 31, 1,228, 1,232-1,234, 1,241.
13. Ray, N.F., Thamer, M., Taylor, T., Fehrenbach, S.N., Ratner, R. (1996). Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991. Journal of Clinical Endocrinology and Metabolism, 81, 3,671-3,679.
14. Todd, W.E., Eichert, J.H., & Toscani, M.R. (1997). Disease management: Building a solid foundation. Disease Management and Health Outcomes, 1(1), 26-33.